Formate Assay Kits

Assay Principle

Formate (formic acid) is the simplest carboxylic acid, and while its physiological concentration is normally low and readily metabolized, it accumulates to toxicologically significant levels following methanol poisoning, where it is the primary agent responsible for the characteristic metabolic acidosis and optic nerve toxicity of methanol exposure. A formate assay typically uses an enzyme-coupled colorimetric chemistry in which formate dehydrogenase (FDH) catalyzes the oxidation of formate using NAD+ as a cofactor, generating NADH. The NADH then transfers electrons through an intermediate electron carrier (phenazine methosulfate, PMS) to a WST-8 tetrazolium salt, producing a yellow formazan product with a characteristic absorption peak at approximately 450 nm.

Protocol highlights and purchasing considerations

Protocol Highlights

Kits are validated for serum, plasma, and animal tissue homogenates, reflecting formate's relevance to both systemic toxicology (blood-based methanol poisoning biomarkers) and tissue-level metabolic studies. Reported sensitivity is in the range of roughly 8 to 800 µmol/L, which comfortably captures both normal low physiological formate levels and the substantially elevated concentrations (reported around 5 mmol/L) associated with methanol toxicity, and assay times run just over an hour. Because the assay's coupled NADH-detection chemistry is shared with several other dehydrogenase-based assays in this series, researchers running multiple metabolite panels should be mindful of potential cross-reactivity from other NAD(P)H-generating reactions in complex tissue lysates. Because endogenous NAD(P)H in the sample can also contribute background signal independent of formate content, kits require a control well to subtract this interference, a detail worth building into the experimental plate layout from the outset.

Assay Kit Purchasing Considerations

Since the FDH-NADH-WST-8 coupled chemistry used to measure formate is standard across suppliers, the practical points of comparison are sensitivity relative to the expected concentration range (normal physiological levels versus toxicological exposure levels differ by roughly two to three orders of magnitude) and validated sample matrix compatibility. For toxicology applications involving suspected methanol or formaldehyde exposure, confirming that a kit's detection range comfortably spans the elevated concentrations expected in acute poisoning cases is important, since a kit optimized purely for low-level physiological measurement may require substantial sample dilution in that context. Given the background interference from endogenous NAD(P)H, researchers should also confirm that a kit's protocol includes a clear control-well strategy before beginning a large study. As with any activity assay, it's good practice to review the full protocol before deciding on a kit, since the manual often reveals practical details, such as incubation times, control requirements, and data analysis steps, that aren't captured in the product summary alone.